P/28/2010 - paediatric investigation plan

dalcetrapib

Key facts

• Active substance:
  dalcetrapib
• Therapeutic area:
  Cardiovascular diseases
• Decision number:
  P/28/2010
• PIP number:
  P/28/2010
• Pharmaceutical form(s):
  Film-coated tablet
• Condition(s) / indication(s):
  Lipoprotein deficiency
• Route(s) of administration:
  Oral use
• Decision type:
  P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
• Decision date:
  05/03/2010
• Compliance check done:
  No

Decision

P/28/2010: European Medicines Agency decision of 5 March 2010 on the agreement of a Paediatric Investigation Plan and on the granting of a deferral and on the granting of a waiver for dalcetrapib (EMEA-000580-PIP01-09) i...

Reference Number: EMA/129196/2010